The study demonstrates that the intranuclear tumor antigens in SV40-transformed hamster cells and SV40-infected monkey cells are immunologically similar or identical.
Answers are grounded in this paper and cite their sources.
No clinical implications for patients; leaves open whether SV40 antigen identity informs human tumor immunology research.
Sera from hamsters bearing tumors induced by papovavirus SV40 reacted with tumor antigen prepared either from cells transformed by, or from cells infected with, the homologous virus. Serum titurs against both antogens were comparable. A high degree if correlation was obtained with the use of either complement‐fixation or immunofluorescence to detect the antigen. The immunoflurescent intranuclear antigen present in cells transformed by SV40, an the early virus‐induced intranuclear antigen found during the cytolytic cycle following infection of monkey cells by SV40, therefore appear to be similar, and they are either identival with or similar to the antigens detected by complement‐fixation techniques. Synthesis of antibody against this antigen was detected only in hamsters bearing tumors induced by SV40 or by cells transformed by the virus. Hamsters immunized with SV40 usually reject cells transformed by the homologous virus; the few vaccinated animals which fail to reject such cells also fail to produce antibodies against tumor antigen although the tumor cells in such animals continue to synthesize the antigen.
No takes yet. Share an insight, caveat, or question.
Kitahara et al. (1966) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: